Tenon Medical Q4 revenue, gross profit surge

Tenon Medical

19/03/2026 20:27

Overview

US medical device maker's Q4 2025 revenue rose 92% yr/yr to $1.5 mln

Gross profit for Q4 2025 increased 188% yr/yr, with gross margin rising to 69%

Outlook

Company did not provide specific guidance for future quarters or the full year in press release

Result Drivers

PROCEDURE GROWTH - Co said FY revenue increase was primarily due to more surgical procedures in the second half of 2025 across Catamaran and SImmetry+ platforms, driven by adoption from new physician users

GROSS MARGIN IMPROVEMENT - Co said higher revenue in second half of 2025 led to better absorption of fixed costs, improving gross margin

Company press release: ID:nACS48z54a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$1.5 mln
$1.38 mln (2 Analysts)
Q4 Net Income
-$2.8 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Tenon Medical Inc is $2.75, about 231.3% above its March 18 closing price of $0.83

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)